Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates

BMC Musculoskeletal Disorders

Volumn 16, Issue 1, 2015, Pages

  Molina, Emily ^a   Del Rincon, Inmaculada ^a   Restrepo, Jose Felix ^a   Battafarano, Daniel F ^b   Escalante, Agustin ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

Death certificates; Epidemiology; Mortality; Rheumatoid arthritis

Indexed keywords

ADULT; AGE; AGED; ARTHROPATHY; ARTICLE; BODY MASS; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEATH CERTIFICATE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SOCIAL STATUS; CLINICAL TRIAL; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; TEXAS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DEATH CERTIFICATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TEXAS;

EID: 84946487395     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0727-7     Document Type: Article

References (27)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008;58:15-25.
2. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35-61.
3. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999;26:2529.
4. Benn RT, Wood PHN. Mortality in rheumatoid arthritics. Br J Prev Soc Med. 1972;26:60.
5. Atwater EC, Jacox RF. The death certificate in rheumatoid arthritis. Arthritis Rheum. 1967;10:259.
6. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: eleven-year follow-up of an epidemiological study. Scand J Rheumatol. 1981;10(4):301-6.
7. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337-47.
8. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol. 2006;2:99-106.
9. Ruyssen-Witrand A, Fautrel B, Saraux A, Le Loët X, Pham T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine. 2011;78:23-30.
10. Ethgen O, de Lemos EF, Bruyere O, Reginster JY. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opin. 2013;29:1147-60.
11. Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2014;66:264-72.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. Escalante A, del Rincón I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum. 1999;42:1712-21.
14. Escalante A, del Rincon I. The disablement process in rheumatoid arthritis. Arthritis Rheum. 2002;47:333-42.
15. Escalante A, del Rincón I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res. 2000;13(3):156-67.
16. Nam CB, Powers MG. The socioeconomic approach to status measurement with a guide to occupational and socioeconomic status scores. Houston: Cap & Gown Press; 1983.
17. Orces CH, Del Rincón I, Abel MP, Escalante A. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum. 2002;47:67-72.
18. del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA- DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum. 2002;46:1480-8.
19. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985;28:1326-35.
20. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. JAMA. 1949;140:659-66.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
22. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34:73-84.
23. Navarro Cano G, del Rincón I, Pogosian S, Roldán JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum. 2003;48:2425-33.
24. Calvo-Alen J, Alarcón GS, Campbell R, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology. 2005;44:1186-9.
25. Nowels D. Completing and signing the death certificate. Am Fam Physician. 2004;70:1813-8.
26. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54-8.
27. Lakkireddy DR, Gowda MS, Murray CW, Basarakodu KR, Vacek JL. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am J Med. 2004;117:492-8.